Analyst
TD Cowan
Equibles does not estimate personal net worth.
Chris is recorded as Analyst at TD Cowan. Chris has spoken on 4 earnings calls across 3 companies, most recently for Cognex Corp on August 6, 2026. Those appearances were for Zoetis Inc. (ZTS), Cognex Corp (CGNX) and Ralliant Corp (RAL). The companies whose calls Chris spoke on are classified in the Healthcare and Technology sectors.
“So this is the first time that Cognex has issued full-year guidance alongside 2Q results. What has changed in the outlook that gives you confidence and visibility to provide the full year at this stage?”
“So are you able to give us any more color on the timing and the conversion cadence of the $1 billion space and defense backlog and how you expect that to ramp relative to the current defense revenue profile?”
“First, what is Zoetis' level of interest and confidence in FTC approval of large-scale transformational business development?”
“First, it seems like the Trump administration is pursuing pharmaceutical tariffs under a Section 232 national security claim. Based on your interactions with Washington, are animal health products viewed as critical to U.S. national security?”
TD Cowan
Analyst
Transcript header (unverified)
ZTS
Drug Manufacturers - Specialty & Generic · Healthcare
CGNX
Scientific & Technical Instruments · Technology
RAL
Electronic Components · Technology
